Patents : |  |
| US Patent No. | Title |
| 7582634 | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
|
| 7589190 | Potent LNA oligonucleotides for the inhibition of HIF-1A expression
|
| 7591994 | Camptothecin-binding moiety conjugates
|
| 7592010 | Albumin fusion proteins
|
| 7592152 | Chondroitinase ABC I and methods of analyzing therewith
|
| 7592332 | Cytokine inhibitors
|
| 7592342 | Quinoxaline derivatives as PI3 kinase inhibitors
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7595158 | Bcl2L12 polypeptide activators and inhibitors
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7598221 | Synthetic HLA binding WT-1 peptide analogues and uses thereof
|
| 7589092 | Prodrugs of heteroaryl compounds
|
| 7588895 | Biomarkers for oral tongue cancer metastasis and extracapsular spread (ECS)
|
| 7582636 | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
|
| 7582645 | Pyrimidine derivatives for treatment of hyperproliferative disorders
|
| 7582744 | Chemically modified oligonucleotides
|
| 7582756 | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
|
| 7585509 | Erb-2 receptor targeting peptide
|
| 7585642 | Methods for evaluating the quality of a heparin sample
|
| 7585868 | Substituted pyrazolo[3,4-D]pyrimidines as kinase antagonists
|
| 7585888 | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
|
| 7585976 | Hemiasterlin derivatives and uses thereof
|
| 7585985 | Substituted benzopyrans as selective estrogen receptor-beta agonists
|
| 7598287 | Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
|
| 7598341 | Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7612062 | Pyrrolobenzodiazepines
|
| 7612178 | Anti-IGF-1R antibodies and uses thereof
|
| 7615221 | Compositions and methods for treating cancer
|
| 7615379 | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
|
| 7615535 | Inhibiting GS-FDH to modulate no bioactivity
|
| 7615539 | Nucleic acid-lipophilic conjugates
|
| 7615618 | Oligonucleotides comprising a non-phosphate backbone linkage
|
| 7618936 | Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)
|
| 7618965 | (Arylamidoanilino)nitroethylene compounds
|
| 7618992 | Method of treating cancer by co-administration of anticancer agents
|
| 7612057 | Supramolecular complexes as photoactivated DNA cleavage agents
|
| 7611892 | Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
|
| 7601355 | Compositions and methods for altering immune function
|
| 7601719 | Compounds, methods and pharmaceutical compositions for inhibiting PARP
|
| 7605138 | Nucleic acid compositions for stimulating immune responses
|
| 7608267 | Multifunctional cytokines
|
| 7608392 | Diagnostic assay for measuring a cell mediated immune response
|
| 7608618 | Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1
|
| 7608628 | Alkylsulphonamide quinolines
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7608638 | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7619100 | Physiologically active substances
|
